Nebraska Medicine - Village Pointe — Omaha, Nebraska

Nebraska Medicine - Village Pointe is a clinical research site located in Omaha, Nebraska, United States 68118.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Medicine - Village Pointe has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Medicine - Village Pointe?

Nebraska Medicine - Village Pointe has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Medicine - Village Pointe conducted?

Nebraska Medicine - Village Pointe has 2 clinical trials on record, with 1 currently active. Their work covers Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.

Is Nebraska Medicine - Village Pointe accredited by Crixeo Health?

Nebraska Medicine - Village Pointe has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Medicine - Village Pointe?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.